Medicine and Dentistry
Esophageal Cancer
100%
Patient
96%
Stomach Cancer
45%
Age
41%
Malignant Neoplasm
38%
Cohort Analysis
33%
Hazard Ratio
31%
Odds Ratio
30%
Male
30%
Association
28%
Mortality
28%
Therapeutic Procedure
25%
Esophageal Adenocarcinoma
25%
Feedback System
22%
Prostaglandin Endoperoxide
22%
Atrophy
22%
Breast Cancer
22%
Furosemide
22%
Disease Exacerbation
22%
Adaptation
22%
COVID-19
22%
Inflammatory Bowel Disease
22%
Diagnosis
22%
Case-Control Study
22%
Drug Therapy
21%
Assessment
18%
Intestinal Metaplasia
17%
Biological Marker
17%
Bisphosphonate
16%
Student
16%
Upper Gastrointestinal Cancer
15%
Cancer Risk
15%
Stress Reduction
15%
Analysis
14%
Incidence
14%
Spironolactone
13%
Medication
12%
Inpatient
12%
Prospective Study
12%
Logistic Regression Analysis
11%
Man
11%
Sex Hormone
11%
Pilus
11%
Proportional Hazards Model
11%
Agonist
10%
Person
10%
Sphincter
10%
Cancer Registry
8%
Resuscitation
8%
Cancer Incidence
7%
Nursing and Health Professions
Esophageal Adenocarcinoma
41%
Famotidine
26%
Cancer Risk
24%
Stomach Cancer
21%
Patient
20%
Odds Ratio
19%
Esophagus Cancer
16%
Confidence Interval
16%
Survival
15%
Tetracycline
13%
Spironolactone
13%
Malignant Neoplasm
12%
Case-Control Study
11%
Biobank
10%
Hazard Ratio
8%
Time
7%
Control
7%
Sugar
7%
Pepsinogen I
7%
Prospective Cohort Study
7%
Procedures
7%
Electronic Prescribing
7%
Prognosis
7%
Proportional Hazards Model
5%
Neoplasm
5%
Esophageal Squamous Cell Carcinoma
5%
Inpatient
5%
Biochemistry, Genetics and Molecular Biology
Association
26%
Statin
22%
Physical Activity
22%
Genetic Divergence
22%
Mortality
20%
Survival
17%
Reduction (Chemistry)
13%
Smoking
9%
Sex
9%
Body Mass
9%
Age
9%
Cancer Survival
7%
Prospective Cohort Study
7%
Cohort Study
7%
Genetic Susceptibility
7%
Genetics
7%
Time
5%
Dose Response
5%
Electric Potential
5%
Taxonomy
5%
Cancer Registry
5%
Angiotensin Receptor
5%